Pharmacyclics, Inc. (PCYC) Tops Q1 EPS by 39c

Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q1 EPS of $1.14, $0.39 better than the analyst estimate of $0.75. Revenue for the quarter came in at $102.7 million versus the consensus estimate of $87.64 million.

For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yum! Brands (YUM) PT Lowered to $180 at Argus
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30